Onconova Presents Positive Data rom Phase 2 Combination Trial of Oral Rigosertib and Azacitidine at #ASH2015

By: via Benzinga
Onconova Therapeutics, Inc. (NASDAQ: ONTX) today announced the presentation of data from an ongoing Phase 1/2 clinical trial of oral ...
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.